Fat-Soluble Statins May Alter Liver Ca Risk in Chronic Hepatitis

Share this post

Data from a nationwide population with confirmed viral hepatitis suggest that fat-soluble statins may exert unique, class-specific hepatoprotective effects.
Medscape Medical News

This post was syndicated from Medscape Medical News Headlines. Click here to read the full text on the original website.


Share this post

Be the first to comment

Leave a Reply